
.
David O'Reilly PhD
Group Scientific Director
Welcome to Research & Development at British American Tobacco, where you will find an overview of our current research and development programmes, research data and recently published papers and posters.
Cigarette smoking is a cause of serious and fatal diseases, so our research and development activities are principally focused on better understanding the mechanisms of harm caused by tobacco use and on developing potentially less harmful products which address this issue. The science of tobacco harm reduction is complex, extremely challenging and spans many scientific disciplines. We have significantly expanded our research capabilities and expenditure over the past few years to reflect the importance we place on work in this area.
We welcome your comments on this website and are pleased to discuss our science or possible collaboration with other scientists working in related areas.
Lower Ignition Propensity (LIP) cigarettesLIP cigarettes are designed to self extinguish under controlled laboratory conditions. On the 17th November 2011, new LIP regulations were introduced in the EU as a general product safety standard.
These pages detail the new regulations, LIP testing standards and provide questions and answers surrounding the LIP environment.
Click here to find out more

In vitro assessment involves identifying and developing in vitro assays which model pathological processes in key smoking-related diseases. We hope these models will provide us with laboratory based data that the smoke from modified tobacco products may have a reduced biological effect.

We continue to publish our scientific research findings in peer reviewed journals. A percentage of these manuscripts are published open access. These manuscripts can be freely downloaded and viewed without subscriptions.